Literature DB >> 12517770

Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.

Masaharu Akiyama1, Teru Hideshima, Toshiaki Hayashi, Yu-Tzu Tai, Constantine S Mitsiades, Nicholas Mitsiades, Dharminder Chauhan, Paul Richardson, Nikhil C Munshi, Kenneth C Anderson.   

Abstract

Sustained proliferation of cancer cells requires telomerase to maintain telomeres that regulate chromosomal stability and cellular mitosis. Expression of human telomerase reverse transcriptase (hTERT) catalytic subunit, which modulates telomerase activity, is regulated at both the transcriptional level and via phosphorylation by Akt kinase. Moreover, nuclear localization of hTERT is required to promote elongation of telomere sequences. In this study, we show for the first time that hTERT protein interacts directly with nuclear factor (NF)-kappaB p65 in MM.1S cells. Importantly, tumor necrosis factor alpha (TNFalpha) modulates telomerase activity by inducing translocation from the cytoplasm to the nucleus of hTERT protein bound to NF-kappaB p65. Conversely, a specific IkappaB kinase (IKK) inhibitor PS-1145, and a specific NF-kappaB nuclear translocation inhibitor SN-50, both block TNFalpha-induced hTERT nuclear translocation. These studies suggest that NF-kappaB p65 plays a pivotal role in regulating telomerase by modulating its nuclear translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

Review 1.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

2.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway.

Authors:  Manoj K Pandey; Bokyung Sung; Kwang Seok Ahn; Ajaikumar B Kunnumakkara; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Blood       Date:  2007-08-02       Impact factor: 22.113

Review 3.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

Review 4.  Telomeres and immunological diseases of aging.

Authors:  Nicolas P Andrews; Hiroshi Fujii; Jörg J Goronzy; Cornelia M Weyand
Journal:  Gerontology       Date:  2009-12-17       Impact factor: 5.140

Review 5.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

6.  Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.

Authors:  Nathaniel J Robinson; Derek J Taylor; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-06

7.  Maternal pro-inflammatory state during pregnancy and newborn leukocyte telomere length: A prospective investigation.

Authors:  Claudia Lazarides; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; Manuel C Voelkle; Claudia Buss; Hyagriv N Simhan; Pathik D Wadhwa; Sonja Entringer
Journal:  Brain Behav Immun       Date:  2019-04-08       Impact factor: 7.217

Review 8.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

9.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

10.  Immunohistochemical localization of hTERT protein in human tissues.

Authors:  Pu Yan; Jean Benhattar; Walter Seelentag; Jean-Christophe Stehle; Fred T Bosman
Journal:  Histochem Cell Biol       Date:  2004-05-07       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.